Carbazochrome

ID: ALA2051960

Max Phase: Phase

Molecular Formula: C10H12N4O3

Molecular Weight: 236.23

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Synonyms: Adrenochrome monosemicarbazone | Adrenochrome semicarbazone | NSC-73742

Canonical SMILES:  CN1CC(O)C2=C/C(=N/NC(N)=O)C(=O)C=C21

Standard InChI:  InChI=1S/C10H12N4O3/c1-14-4-9(16)5-2-6(12-13-10(11)17)8(15)3-7(5)14/h2-3,9,16H,4H2,1H3,(H3,11,13,17)/b12-6-

Standard InChI Key:  XSXCZNVKFKNLPR-SDQBBNPISA-N

Molfile:  

     RDKit          2D

 17 18  0  0  0  0  0  0  0  0999 V2000
    0.8545   -4.7084    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0679   -5.5048    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4313   -4.1186    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8623   -5.7273    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0417   -4.6605    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.4640   -5.1562    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2378   -4.3123    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3880   -5.9527    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2532   -5.3800    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.6293   -5.0622    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2412   -5.4401    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8311   -4.8153    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.8094   -3.7239    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.2352   -4.5069    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.8222   -5.8245    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.3117   -6.7758    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4366   -3.9831    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  1  0
  3  1  2  0
  4  2  2  0
  5  1  1  0
  6  7  1  0
  7  3  1  0
  8  2  1  0
  9  6  2  0
 10 12  1  0
 11  5  1  0
 12  9  1  0
 13  7  2  0
 14 10  2  0
 15 10  1  0
 16  8  1  0
 17  5  1  0
  8 11  1  0
  4  6  1  0
M  END

Alternative Forms

  1. Parent:

    ALA2051960

    CARBAZOCHROME

Associated Targets(non-human)

SARS-CoV-2 (38078 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 236.23Molecular Weight (Monoisotopic): 236.0909AlogP: -1.29#Rotatable Bonds: 1
Polar Surface Area: 108.02Molecular Species: NEUTRALHBA: 5HBD: 3
#RO5 Violations: HBA (Lipinski): 7HBD (Lipinski): 4#RO5 Violations (Lipinski):
CX Acidic pKa: 11.64CX Basic pKa: 1.98CX LogP: -1.22CX LogD: -1.22
Aromatic Rings: Heavy Atoms: 17QED Weighted: 0.39Np Likeness Score: 0.20

References

1. Kruhlak NL, Choi SS, Contrera JF, Weaver JL, Willard JM, Hastings KL, Sancilio LF..  (2008)  Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.,  18  (2): [PMID:20020916] [10.1080/15376510701857262]
2. USP Dictionary of USAN and International Names (2010 edition) and USAN registrations 2007-date, 
3. PubChem BioAssay data set, 
4. WHO Anatomical Therapeutic Chemical Classification, 
5. Franck Touret, Magali Gilles, Karine Barral, Antoine Nougairède, Etienne Decroly, Xavier de Lamballerie, Bruno Coutard.  (2020)  In vitro screening of a FDA approved chemical library reveals potential inhibitors of SARS-CoV-2 replication,  [10.1101/2020.04.03.023846]
6. Katie Heiser, Peter F. McLean, Chadwick T. Davis, Ben Fogelson, Hannah B. Gordon, Pamela Jacobson, Brett Hurst, Ben Miller, Ronald W. Alfa, Berton A. Earnshaw, Mason L. Victors, Yolanda T. Chong, Imran S. Haque, Adeline S. Low, Christopher C. Gibson.  (2020)  Identification of potential treatments for COVID-19 through artificial intelligence-enabled phenomic analysis of human cells infected with SARS-CoV-2,  [10.1101/2020.04.21.054387]